FARAWAVE™ Pulsed Field Ablation Catheter

FARAWAVE is an over-the-wire pulsed field ablation (PFA) catheter with two form factors, basket and flower, to successfully ablate the pulmonary vein in a wide range of unique patient anatomies.

Configure or select a product to continue to order

How it works

FARAPULSE™ Pulsed Field Ablation System, the world's clinical leader in PFA, delivers a proprietary waveform to preferentially ablate cardiomyocytes, which have lower thresholds to electric field damage than surrounding tissue—treating atrial fibrillation (AFib) effectively while minimizing risk of thermal complications.

Why choose FARAWAVE Pulsed Field Ablation Catheter

Optimized catheter design

The FARAWAVE PFA Catheter has been optimized to achieve catheter placement in a wide range of pulmonary vein (PV) anatomies and address PFA energy delivery needs without the need to manually manage electrode activation.

Featuring two different form factors (basket and flower positions), the FARAWAVE PFA Catheter is purposefully designed to optimize:

  • Maneuverability
  • Placement in variable-anatomy veins
  • Potential for application outside PVs
  • Standardized electrode activation (manual electrode activation is not required)
alt text
alt text

Non-thermal ablation

FARAWAVE uses a proprietary waveform to preferentially ablate cardiac cells—reducing the risk of collateral structure damage.

  • ADVENT trial: FARAPULSE met all primary endpoints for safety and efficacy1 (posterior probability >0.999)
  • MANIFEST-17K Registry (17,000+ pts): no reported esophageal fistula, permanent phrenic nerve palsy, and pulmonary vein stenosis.2
alt text

Optimized dosing

The FARAPULSE dosing protocol delivers durable lesions via a streamlined workflow using multiple distal shapes in a prescribed series with a single catheter.

  • Propensity-Matched Study: PV reconnection rate significantly lower for FARAPULSE vs. cryoballoon ablation and radiofrequency ablation.3
alt text

Predictable and reproducible workflow

The FARAPULSE workflow is predictable and reproducible, while reducing procedural duration variability.

  • PFA ablation time significantly lower, with an average reduction of 42% vs. thermal ablation.1

For use with the
FARAPULSE™ PFA System

Example image.
null

Discover what peers are saying about FARAPULSE

Hear firsthand from physicians as they share their excitement about the
transformative FARAPULSE experience.


Required products



References:

1. Reddy VY, Gerstenfeld EP, Natale A, et al., Pulsed field or conventional thermal ablation for paroxysmal atrial fibrillation. New England Journal of Medicine. 2023;Nov2;389(18):1660-1671. doi:10.1056/NEJMoa2307291

2. Ekanem, E., Neuzil, P., Reichlin, T. et al. Safety of pulsed field ablation in more than 17,000 patients with atrial fibrillation in the MANIFEST-17K study. Nat Med (2024). https://doi.org/10.1038/s41591-024-03114-3

3. Della Rocca DG, Marcon L, Magnocavallo M, et al., Pulsed electric field, cryoballoon, and radiofrequency for paroxysmal atrial fibrillation ablation: a propensity score-matched comparison, EP Europace, 2024;Jan26(1) euae016. doi.org/10.1093/europace/euae016